1. Home
  2. ORN vs ENTA Comparison

ORN vs ENTA Comparison

Compare ORN & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Orion Group Holdings Inc.

ORN

Orion Group Holdings Inc.

HOLD

Current Price

$12.20

Market Cap

411.7M

Sector

Industrials

ML Signal

HOLD

Logo Enanta Pharmaceuticals Inc.

ENTA

Enanta Pharmaceuticals Inc.

HOLD

Current Price

$13.93

Market Cap

374.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ORN
ENTA
Founded
1994
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
411.7M
374.6M
IPO Year
2007
2012

Fundamental Metrics

Financial Performance
Metric
ORN
ENTA
Price
$12.20
$13.93
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
5
Target Price
$16.25
$20.40
AVG Volume (30 Days)
224.5K
110.8K
Earning Date
04-28-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
220.00
29.93
EPS
0.06
N/A
Revenue
$852,260,000.00
$102,814,000.00
Revenue This Year
$8.50
$7.76
Revenue Next Year
$7.83
N/A
P/E Ratio
$199.50
N/A
Revenue Growth
7.01
16.48
52 Week Low
$5.88
$4.96
52 Week High
$15.00
$17.15

Technical Indicators

Market Signals
Indicator
ORN
ENTA
Relative Strength Index (RSI) 58.36 54.19
Support Level $10.34 $13.75
Resistance Level $13.17 $15.52
Average True Range (ATR) 0.44 0.68
MACD 0.14 0.11
Stochastic Oscillator 96.32 63.77

Price Performance

Historical Comparison
ORN
ENTA

About ORN Orion Group Holdings Inc.

Orion Group Holdings Inc is a specialty construction company serving the infrastructure, industrial, and building sectors, providing services both on and off the water in the continental United States, Alaska, Canada, and the Caribbean Basin through its marine segment and its concrete segment. Its marine segment provides construction and dredging services relating to marine transportation facility construction, marine pipeline construction, marine environmental structures, dredging of waterways, channels and ports, environmental dredging, design, and specialty services. The concrete segment generates maximum revenue and provides construction services for commercial, industrial, multi-family residential, and public projects, including the data center market.

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

Share on Social Networks: